SeaStar Medical Holding Corporation Warrant (ICUCW)
Company News
SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025
SeaStar Medical announced progress in its NEUTRALIZE-AKI pivotal trial for acute kidney injury treatment, reaching over 60% enrollment with 125 of 200 anticipated patients and 16 clinical trial sites activated.